Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells
Shuang Liu(Army Medical University), Jianxiang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shouyun Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingxi Xu(Tianjin University of Technology), Shuzu Zhang, Qing Rao(Chinese Academy of Medical Sciences & Peking Union Medical College), Haiyan Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jia Liu(Sun Yat-sen University), Wenting Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Saisai Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuanyuan Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Chengjun Deng(Chinese Academy of Medical Sciences & Peking Union Medical College), Joe Z. Zhou(Pfizer (United States))
Cited by 20
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
|Molecular Cancer|2019|549
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
|Cell Systems|2018|452
MicroRNA-103/107 Regulate Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury Through Targeting FADD
|Circulation Research|2015|274
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
|Nature Communications|2020|258